ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025
Development of Survey Measures of Uncontrolled Vaping and Vaping Restraint.
Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and correlates of uncontrolled vaping among US adults.Journal of behavioral medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionSome e-cigarette users experience uncontrolled vaping, defined as using vapes more than preferred. Because validated measures of this experience are lacking, this study aimed to develop and validate scales measuring uncontrolled vaping and vaping restraint among US adults and youth.
methodsWe developed new survey measures of uncontrolled vaping and vaping restraint based on qualitative research and refined them after cognitive interviews. In Study 1, we used data from a convenience sample of 950 US adult e-cigarette users to establish psychometrically sound scales. In Study 2, we used data from a nationally representative sample of 1,138 US adolescents and adults to finalize the scales.
resultsStudy 1 produced reliable scales for uncontrolled vaping perception (five items), uncontrolled vaping consequences (four items), and vaping restraint (four items) (αs = .87-.93). Convergent and criterion validity were demonstrated by stronger associations of uncontrolled vaping with use behaviors (median r = .65 vs. .39) and somewhat weaker associations with measures of limiting use (median r = .44 vs. .51). Higher vaping restraint scores were associated with measures of limiting use (r = .46 to .59) and quit intentions (r = .23 to .48). Study 2 confirmed these results and further refined the scales to three items each.
conclusionThe newly developed scales for uncontrolled vaping and vaping restraint demonstrated sound psychometric properties in both convenience and nationally representative samples. These measures can inform e-cigarette regulatory actions and guide the development of vaping management and cessation approaches. IMPLICATIONS: This study introduces reliable and valid scales to measure uncontrolled vaping perceptions, uncontrolled vaping consequences, and vaping restraint among e-cigarette users. These tools provide a nuanced understanding of vaping behaviors, distinguishing internal perceptions of overuse from external consequences such as feedback from others or interference with daily activities. By capturing these dimensions, the scales offer insights beyond traditional nicotine dependence measures, supporting research and interventions tailored to vaping-specific challenges. The findings highlight the importance of addressing uncontrolled vaping through regulatory and clinical efforts, informing strategies to reduce excessive vaping, and promoting self-regulation among e-cigarette users.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.